NEW YORK (Reuters) - Pfizer Inc reported higher second-quarter earnings, as booming sales of animal health products that company aims to divest helped offset falling sales of its core pharmaceuticals business.
The world's biggest drugmaker said on Tuesday that it earned $2.61 billion, or 33 cents per share, compared with $2.48 billion, or 31 cents per share, in the year-earlier quarter.
Excluding special items, Pfizer earned 60 cents per share. Analysts on average expected 59 cents, according to Thomson Reuters I/B/E/S.
Global revenue of $16.98 billion matched Wall Street expectations.
(Reporting by Ransdell Pierson; Editing by Lisa Von Ahn)